PitchBook：2025年三季度健康科技公开财务报表和估值指南报告（英文版）

Healthtech broadly underperforms: Public healthtech equities underperformed major market indexes in Q3. Stock price performance in the EHRs & clinical information segment has been particularly weak, with share prices down 11% on average so far in 2025. The virtual care & RPM segment has also seen negative returns on average, down 3% YTD. However, recent listings by Hinge Health and Omada posted strong price gains in Q3 and remained well above their listing prices, signaling sustained